Alzheimer's Assocation Research only
All of
  • Go to
  • Research Center
  • AAIC
  • Journal
  • Grants
  • TrialMatch
  • Press
  • Donate
  • Contact Us
Science and Progress
Clinical Trials
Funding and Collaboration
You can Help
Stay Current
Video and Resources

Text Size

Small text Medium text Large text

Research Grants 2013

To view an abstract, select an author from the vertical list on the left.

2013 Grants - Gifford

Cognitive Complaints in Community-Dwelling Adults

Katherine Gifford, Psy.D.
Vanderbilt University Medical Center
Nashville, Tennessee

2013 New Investigator Research Grant

Mild cognitive impairment (MCI) is a condition characterized by mild declines in memory and other brain functions. Many people with mild cognitive impairment go on to develop Alzheimer's disease within a five year period. Studies also show that brain degeneration is severe and irreversible by the time a clinical diagnosis of Alzheimer's is made. Thus, it is vital to identify people with mild cognitive impairment before the dementia-related changes in their brain become too widespread.

In preliminary research, Katherine Gifford, Psy.D., and colleagues have found that at least half of all individuals with mild cognitive impairment go undiagnosed. Primary care physicians often have insufficient time or screening tools to make accurate MCI diagnoses. These problems suggest the need for a fast, reliable, cost-effective method of identifying people with memory deficits who may need further cognitive testing.

For their grant, Dr. Gifford and colleagues will assess the prevalence of "cognitive complaints" in a group of middle-aged and older individuals in Nashville, Tennessee. Recent studies have found cognitive complaints, which include frustration over memory loss, may be an early indicator of unhealthy brain aging. The team will then work with another participant group in Nashville to develop a set of questions for reliably measuring the severity of a person's cognitive complaints. Dr. Gifford's team hopes this questionnaire might represent a cost-effective tool for physicians to use to identify a wider variety of people at the early stages of dementia.

Alzheimer's Association International Conference | July 16-20, 2017, London, England

Abstract Submissions Now Open

The Scientific Program Committee is now accepting submissions for poster
presentations, oral presentations and featured research sessions.